jacmar: 20 million in revenue represents at least
Post# of 30028
Posted On: 01/05/2015 7:27:47 PM
jacmar: 20 million in revenue represents at least a market cap value of 160 million. With about 900 million outstanding shares that means Lympro is worth close to .20 cents by itself! I think that is a fair valuation.
No one really knows how to accurately attribute market cap value from Eltoprazine, ESS, MANF, and Phenoguard. But.....this is where irrational exuberance comes into play. Once the LymPro revenue train starts.....the market will be excited and more willing to speculate on our therapeutic drugs.
I still cannot see being under .20 cents by February. From there who knows, but I'd be happy with a March 1st up list in the .30 to .40 cent range. (Pre-RS)
I don't think Gerald will sell out LymPro yet. I think each month its value will multiply. Maybe toward the end of 2015 after it has been spun off and is generating revenue and surprising everyone some Big Pharma will buy it out for somewhere between 500 million to one billion! But that would be at least 8 to 16 months away.
No one really knows how to accurately attribute market cap value from Eltoprazine, ESS, MANF, and Phenoguard. But.....this is where irrational exuberance comes into play. Once the LymPro revenue train starts.....the market will be excited and more willing to speculate on our therapeutic drugs.
I still cannot see being under .20 cents by February. From there who knows, but I'd be happy with a March 1st up list in the .30 to .40 cent range. (Pre-RS)
I don't think Gerald will sell out LymPro yet. I think each month its value will multiply. Maybe toward the end of 2015 after it has been spun off and is generating revenue and surprising everyone some Big Pharma will buy it out for somewhere between 500 million to one billion! But that would be at least 8 to 16 months away.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼